Compare ARK Genomic Revolution ETF (ARKG) vs Expensify Inc (EXFY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Expensify Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Expensify Inc trades at $1.89 (market cap $182.27M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Expensify Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | EXFY | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $2.33 |
52-Week Low | $23.09 | $0.75 |
Market Cap | — | $182.27M |
Enterprise Value | — | $121.30M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EXFY trades at $1.89, down 3.08% today, with a bullish technical signal from moving averages and oscillators. The company reported Q1 2026 EPS of $0.04, beating expectations, but maintains negative net income margins. Recent news highlights AI expansion and a $25 million stock buyback program, indicating management confidence despite financial challenges.
Outlook remains mixed with strong analyst buy ratings (44%) but persistent profitability issues. Key opportunities include AI product growth and cash flow stability, while risks involve sustained losses and competitive pressures. The stock presents a speculative opportunity with high volatility potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →
